Anzeige
Mehr »
Donnerstag, 08.01.2026 - Börsentäglich über 12.000 News
Steht diese NASDAQ-Biotech-Aktie jetzt vor einer seltenen Kaufgelegenheit?
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche
PR Newswire
278 Leser
Artikel bewerten:
(1)

Alphagreen Launches New Service Venture NUOPTIMA

- Services arm 'NUOPTIMA' announced for accelerating highly regulated industries - Multiple healthcare and emerging industry firms join as new signees - Experienced product marketing and advertising executive Ruth Zohrer to join Alphagreen Group's Advisory Board

LONDON, Feb. 9, 2021 /PRNewswire/ -- Alphagreen, Europe's leading marketplace for alternative healthcare products, has announced the launch of NUOPTIMA, their new services arm, following a £1.1m raise in seed funding last year.

As part of the Alphagreen Group, NUOPTIMA will help ambitious brands in emerging industries scale faster by providing a full-service growth platform. Key features of NUOPTIMA include:

  • Reach - SEO, influencer marketing, and paid traffic services
  • Convert - Creative services, email marketing, and customer service
  • Run - Set up and manage CMS, Omnichannel management, and distribution between U.S. and UK as well as UK and EU

With the launch of its new services arm, Alphagreen Group will be focused on helping emerging brands reach their audience faster, convert their visitors into customers, and make operations more cost-effective from a fulfillment and online services perspective.

At the time of public launch, NUOPTIMA already counts several healthcare and wellness brands as its clients, including Infused Amphora, Goodbody, VAAY, Mantle, and CBII (part of the H&H group) as well as fintech brand MarketFinance.

NUOPTIMA was trialled in 2020 with the scaling of Alphagreen.io. In just six months, Alphagreen grew to become Europe's largest CBD and Alternative Healthcare marketplace. With continued CBD and Cannabis market growth at 22% annually - projected to be $100 billion by 2026 - more companies are lining up to utilize the platform to take advantage of the industry's surge.

"By providing an end-to-end platform for brands, covering reach, conversion, accelerated growth, localisation, and fulfilment, we're streamlining a set of disciplines and processes for a booming industry," said Alexej Pikovsky, co-founder and CEO of Alphagreen. "We've seen incredible results with the growth of Alphagreen.io to European market leader, and we're eager to replicate and build on this success with some of the most exciting new startups in emerging healthcare."

To support the growth of Alphagreen Group's portfolio, experienced product marketing and advertising executive Ruth Zohrer has joined the company in an advisory capacity. Ruth was responsible for the buy-side services team for AppNexus (now Xandr) in Europe, and brings integral knowledge on building and scaling platform services to Alphagreen. Additionally, Ruth's wealth of experience in branding, media, and marketing strategy honed through several leadership roles within Mindshare - the Top Media Agency Network according to WARC - provides an indispensable advantage to Alphagreen's development in brand, advertising, and data proposition growth.

"I am delighted and honoured to join the advisory board of Alphagreen Group. Alphagreen's success at building and growing a direct-to-consumer marketplace proposition in a highly regulated industry in such a short timeline is a testament to the excellent capabilities that Alexej and the team have built in-house. The alternative healthcare space is an exciting industry, and I can't think of a team better placed to capitalise on its opportunity than Alphagreen." - Ruth Zohrer.

For additional information please contact:

Kevin Maxwell, Kevin@shift6.org, +44 7985 351 797 (UK and Europe)

Melissa Tirey, Melissa@shift6.org, +1 646 823 6776 (New York)

Rhian Humphries, Rhian@shift6.org, +1 408 412 2957 (West Coast)

About Alphagreen Group:

Alphagreen Group is an e-commerce platform and technology provider. The group is focused on emerging e-commerce verticals such as CBD, Medical Cannabis, Nootropics, and Sexual Wellbeing, alongside new exciting brands within the health, wellness and beauty space. Founded in 2019, Alphagreen was born from a passion for health and wellbeing, combined with technology and innovation. Alphagreen is the brainchild of entrepreneurs Alexej Pikovsky and Viktor Khliupko, who encourage you to "Alpha Up Your Life." Alphagreen was created to simplify the entire experience with alternative healthcare products along every step of the consumer journey.

Related Files

Screen Shot 2021-02-08 at 12.06.06 PM.png

Screen Shot 2021-02-08 at 12.08.29 PM.png

© 2021 PR Newswire
Renditeturbo 2026 - 5 Aktien mit Potenzial
2025 neigt sich dem Ende zu, ohne klassische Jahresendrallye, aber mit einem DAX, der viele Kritiker Lügen gestraft hat. Über 21 Prozent Kursplus seit Jahresbeginn, stärker als der US-Markt. Wer hätte das noch vor Monaten erwartet?

Genau solche Entwicklungen machen den Reiz der Börse aus. Denn auch 2026 dürfte wieder alles anders kommen als gedacht. Während viele Analysten weiter steigende Kurse erwarten, rückt eine zentrale Frage in den Fokus: Wo entstehen im kommenden Jahr echte Überraschungen, und wie kann man davon profitieren?

Unser aktueller Spezialreport beleuchtet fünf Entwicklungen, mit denen kaum jemand rechnet, die aber enormes Renditepotenzial bergen. Vom Comeback der Ölwerte über unterschätzte Plattform-Aktien bis hin zur möglichen Wachablösung im KI-Sektor: Wer 2026 überdurchschnittlich abschneiden will, muss antizyklisch denken und frühzeitig Position beziehen.

Im kostenlosen Report stellen wir 5 Aktien vor, die 2026 im Zentrum solcher Wendepunkte stehen könnten. Solide bewertet, gut positioniert und mit überraschend starkem Momentum.

Jetzt kostenlos herunterladen! Bevor andere erkennen, wo die Chancen wirklich liegen!

Dieses exklusive PDF ist nur für kurze Zeit verfügbar.
Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.